OnPAR launched in 2016 in partnership with the National Institute of Health (NIH). OnPAR has now expanded to accept reviewed, high scoring abstracts from all research investigators globally. In the near future, OnPAR will be enhanced to include:
- un-reviewed ideas
- pharmaceutical assets
- other research based collateral
- clinical trials information
OnPAR is a matchmaking platform where applicants and non-government funders come together. Government, private foundations, private foundations, pharmaceutical companies, venture capital funds, and other funds for biomedical research are part of a funding ecosystem that supports global biomedical research. Their goal is to support research and drug development for the advancement of public health. Over the last decade, these organizations have begun working together to build on their complementary strengths. OnPAR is a new funding paradigm that seeks to build public-private partnerships within the funding ecosystem.
The goal of OnPAR is to match quality biomedical research projects with priority areas of interest of private foundations, pharmaceutical and biotech companies and/or other private biomedical research funders to advance research, discovery, and development that will benefit the world.
Partners are national and international government funding agencies who work with Leidos to announce OnPAR to their unfunded, high-scoring applicants. The National Institute of Health (NIH), in the United States, is the founding partner. OnPAR personnel are in conversations with other national and international funders to join OnPAR within the next 6 months.
Click on each organization to access their website.
|Australia National Health and Medical Research Council (NHMRC)|
|National Scientific and Technical Research Council (CONICET)|
|Canadian Institutes of Health Research (CIHR)|
|Fonds de recherché Sante Quebec|
|National Science Foundation of China (NSFC)|
|European Commission (EU)|
|The World Academy of Sciences (TWAS)|
|Japan Agency for Medical Research and Development (AMED)|
|Japan Society for the Promotion of Science (JSPS)|
|Consejo Nacional de Ciencia y Tecnologia of Mexico (CONACYT)|
|Agency for Science, Technology and Research (A*STAR)|
|South Africa Medical Research Council (SAMRC)|
|Cancer Research UK (CRUK)|
|Medical Research Council (MRC)|
|UK Department of Health / National Institute for Health Research (NIHR)|
|Wellcome Trust (WT)|
World Wide Agencies
|World Health Organization (WHO)|